TITLE

Neurological manifestations of Erdheim-Chester disease

AUTHOR(S)
Wright, R. Alan; Hermann, Robert C.; Parisi, Joseph E.
PUB. DATE
January 1999
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Jan1999, p72
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66699701

 

Related Articles

  • Erdheim-Chester Disease Presented with Bilateral Carotid Artery Occlusion: Case Report. Çelik, Yahya; Balcı, Kemal; Asil, Talip; Tüzün, Erdem; Hamamcıoğlu, Mustafa Kemal; Temizöz, Osman; Albayram, Sait; Sav, Aydın // Turkish Journal of Neurology / Turk Noroloji Dergisi;Jun2010, Vol. 16 Issue 2, p110 

    Erdheim-Chester disease is a rare, non-Langerhans form of systemic histiocytosis of unknown etiology. The disease affects multiple organ systems, including musculoskeletal, cardiac, pulmonary, gastrointestinal, and central nervous systems, producing protean manifestations. Neurological...

  • Lesions.  // Current Medical Literature: Neurology;2007, Vol. 23 Issue 1, p23 

    The article presents abstracts of medical research on lesions. They include "Neurological Manifestations and Neuroradiological Presentation of Erdheim-Chester Disease: Report of 6 Cases and Systematic Review of the Literature" and "Stereotactic Biopsy of Brain Stem Masses: Decision Analysis and...

  • Cerebral Erdheim-Chester disease: case report and review of the literature. Weidauer, Stefan; von Stuckrad-Barre, Sebastian; Dettmann, Edgar; Zanella, Friedhelm E.; Lanfermann, Heinrich // Neuroradiology;Apr2003, Vol. 45 Issue 4, p241 

    Erdheim-Chester disease is a rare systemic non-Langerhans histiocytosis of unknown etiology that affects multiple organ systems. Cerebral involvement is most often caused by extra-axial masses of foamy histiocytes, whereas intraparenchymal manifestations are less frequent. Review of the...

  • Treatment of Erdheim-Chester disease with cladribine: a rational approach. Myra, C.; Sloper, L.; Tighe, P. J.; Mclntosh, R. S.; Stevens, S. E.; Gregson, R. H. S.; Sakal, M.; Haynes, A. P.; Pawell, R. J. // British Journal of Ophthalmology;Jun2004, Vol. 88 Issue 6, p844 

    Erdheim-Chester disease is a rare, life threatening lipoid granulomatosis with fewer than 100 cases described in the world literature. The disease typically affects the long bones and symmetrical sclerosis of the diaphyseal and metaphyseal regions is pathognomonic. Extraskeletal manifestations...

  • Myocardial Involvement in Erdheim-Chester Disease. Loeffler, Agnes G.; Memoli, Vincent A. // Archives of Pathology & Laboratory Medicine;Jun2004, Vol. 128 Issue 6, p682 

    The article discusses the myocardial involvement in Erdheim-Chester disease. While the osseous and systemic changes have been well documented in the current literature, pathologic changes in the myocardiurn have not been well characterized. Clinical manifestations of the diseases are bone pain,...

  • Zoledronic acid.  // Reactions Weekly;Mar2014, Vol. 1494 Issue 1, p46 

    An abstract of the study "Erdheim-Chester disease and pituitary involvement: A unique case and the literature," by K. Manaka and colleagues is presented.

  • Sirolimus.  // Reactions Weekly;Mar2014, Vol. 1491 Issue 1, p30 

    An abstract of the article "Sirolimus plus prednisone for erdheim-chester disease: A pilot trial," by D. Gianfreda and colleagues is presented.

  • Treatment of Erdheim–Chester disease with canakinumab. Tran, Tu-Anh; Pariente, Danièle; Guitton, Corinne; Delwail, Adriana; Barat-Houari, Mouna; Meinzer, Ulrich // Rheumatology;Dec2014, Vol. 53 Issue 12, p2312 

    A letter to the editor is presented in response to the article "Treatment of Erdheim-Chester disease with canakinumab" in the September 17, 2014 issue.

  • Erdheim-Chester disease presenting with an intramedullary spinal cord lesion. Tzoulis, Charalampos; Gjerde, Ivar; Søfteland, Eirik; Neckelmann, Gesche; Strøm, Eivind; Vintermyr, Olav; Sviland, Lisbeth; Biermann, Martin // Journal of Neurology;Oct2012, Vol. 259 Issue 10, p2240 

    The article discusses the intramedullary spinal cord lesion presentation in Erdheim-Chester disease. It mentions that Erdheim-Chester disease (ECD) is a rare form of non- Langerhans histiocytosis characterized by multi-systemic xanthogranulomatous infiltration. This disease has several areas of...

  • Erdheim-Chester disease. Akkara Veetil, Bharath; Luthra, Harvinder // Clinical Rheumatology;Mar2011, Vol. 30 Issue 3, p397 

    Erdheim-Chester disease is characterized by long bone pain and symmetric sclerosis of the diametaphyseal portions of the long bones. It is an important differential diagnosis of sclerotic disease of the bones.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics